X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (66) 66
index medicus (61) 61
gastroenterology & hepatology (36) 36
male (34) 34
female (32) 32
hepacivirus - immunology (30) 30
cd8-positive t-lymphocytes - immunology (28) 28
middle aged (25) 25
adult (22) 22
hepatitis c virus (21) 21
virology (20) 20
aged (18) 18
hepatitis c - immunology (18) 18
immune-responses (16) 16
infection (16) 16
further section (15) 15
t cells (15) 15
abridged index medicus (14) 14
health aspects (14) 14
hepatitis (14) 14
hepacivirus - genetics (13) 13
viral clearance (13) 13
epitopes, t-lymphocyte - immunology (12) 12
hepatitis c, chronic - immunology (12) 12
class-i (11) 11
genotype (11) 11
hepatitis c - virology (11) 11
hepatitis c (10) 10
infections (10) 10
mutation (10) 10
pathogenesis and immunity (10) 10
alleles (9) 9
antigens (9) 9
cohort studies (9) 9
gastroenterology and hepatology (9) 9
immunology (9) 9
lymphocytes (9) 9
treatment outcome (9) 9
virus diseases (9) 9
cd8 t-cells (8) 8
lymphocyte response (8) 8
phenotype (8) 8
analysis (7) 7
article (7) 7
cd4-positive t-lymphocytes - immunology (7) 7
cd8-positive t-lymphocytes - virology (7) 7
clinical neurology (7) 7
genetic aspects (7) 7
hepacivirus - physiology (7) 7
hepatitis b (7) 7
hepatitis c, chronic - virology (7) 7
hla-b27 (7) 7
immunological determinants (7) 7
molecular sequence data (7) 7
peripheral vascular disease (7) 7
retrospective studies (7) 7
risk factors (7) 7
source outbreak (7) 7
stroke (7) 7
therapy (7) 7
young adult (7) 7
animals (6) 6
anticoagulants (6) 6
antiviral agents - therapeutic use (6) 6
care and treatment (6) 6
cd4 (6) 6
cells, cultured (6) 6
clearance (6) 6
dendritic cells (6) 6
escape (6) 6
evolution (6) 6
hcv (6) 6
immune response (6) 6
peripheral-blood (6) 6
persistence (6) 6
viral escape (6) 6
viral nonstructural proteins - genetics (6) 6
viruses (6) 6
amino acid sequence (5) 5
cd8-positive t-lymphocytes - metabolism (5) 5
chronic infection (5) 5
development and progression (5) 5
epitopes (5) 5
hepatitis c - genetics (5) 5
hepatitis-c virus (5) 5
hepatocellular carcinoma (5) 5
hiv (5) 5
hla (5) 5
hla-b antigens - genetics (5) 5
hla-b antigens - immunology (5) 5
hla-b27 antigen - immunology (5) 5
immunity (5) 5
immunodominant epitopes - immunology (5) 5
immunotherapy (5) 5
infectious diseases (5) 5
liver (5) 5
liver - immunology (5) 5
liver cirrhosis (5) 5
research (5) 5
responses (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 10/2018, Volume 128, Issue 10, p. 4257
Journal Article
Current Topics in Microbiology and Immunology, ISSN 0070-217X, 2013, Volume 369, pp. 243 - 262
The adaptive immune response plays a central role in the outcome of hepatitis C virus (HCV) infection. Indeed, spontaneous viral clearance is associated with... 
Adaptive Immunity | Hepatitis C - immunology | Animals | Hepacivirus - immunology | Humans | Hepatitis C - virology | Antibodies, Viral - immunology | Hepacivirus - physiology
Conference Proceeding
Journal of Hepatology, ISSN 0168-8278, 10/2019, Volume 71, Issue 4, pp. 648 - 650
Journal Article
Journal Article
JAMA, ISSN 0098-7484, 02/2015, Volume 313, Issue 8, pp. 824 - 836
Journal Article
DMW - Deutsche Medizinische Wochenschrift, ISSN 0012-0472, 04/2019, Volume 144, Issue 8, pp. 520 - 527
Abstract Chronic viral hepatitis can remain unrecognized but may nevertheless lead to liver cirrhosis and hepatocellular carcinoma. Thus, patients with... 
Dossier
Journal Article
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, ISSN 1542-3565, 11/2019
Hepatitis C virus infection is causing chronic liver disease, cirrhosis, and hepatocellular carcinoma. By combining direct-acting antivirals (DAAs), high... 
Journal Article
Gut, ISSN 0017-5749, 02/2015, Volume 64, Issue 2, pp. 193 - 194
  When applying the prediction scores to this cohort, the predicted rates of complications and deaths matched indeed very convincingly with the observed rate... 
COHORT | THERAPY | GASTROENTEROLOGY & HEPATOLOGY | CIRRHOSIS | PROGRESSION | Female | Male | Liver Cirrhosis - virology | Hepatitis C, Chronic - complications | Models, Statistical | Humans | Infections | Liver diseases | Surveillance | Liver cirrhosis | Mortality
Journal Article
BMC INFECTIOUS DISEASES, ISSN 1471-2334, 07/2019, Volume 19, Issue 1, pp. 675 - 5
BackgroundHepatitis E virus (HEV) infection is now recognized as a major cause of acute hepatitis worldwide. HEV specific antibodies develop shortly after... 
INFECTIOUS DISEASES | HEV epitopes | E VIRUS | Hepatitis E virus (HEV) | Antibodies | Chronic infection | Reinfection | Ribavirin
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2014, Volume 61, Issue 3, pp. 538 - 543
Background & Aims Chronic hepatitis C virus (HCV) infection is characterised by a failure of virus-specific CD8+ T cells that is mainly caused by viral escape... 
Gastroenterology and Hepatology | T cell exhaustion | Antiviral therapy | Immune response | Hepatitis C virus | T cell restoration | DAA | CD127 EXPRESSION | PHENOTYPE | CD8(+) T-CELLS | RESPONSES | INHIBITION | HEPATITIS-C VIRUS | CD4(+) | INFECTION | VIRAL PERSISTENCE | GASTROENTEROLOGY & HEPATOLOGY | PD-1 | Acrylates - therapeutic use | Hepatitis C, Chronic - pathology | CD8-Positive T-Lymphocytes - pathology | Humans | Middle Aged | Male | Recombinant Proteins | Thiazoles - therapeutic use | Contraindications | Oligopeptides - therapeutic use | Acrylates - pharmacology | Adult | Female | Hepacivirus - physiology | Drug Therapy, Combination | Benzimidazoles - therapeutic use | Hepacivirus - drug effects | Virus Replication - drug effects | Antiviral Agents - pharmacology | Polyethylene Glycols | Antiviral Agents - therapeutic use | Interferon-alpha | Ribavirin - therapeutic use | Cell Proliferation - physiology | Cells, Cultured | Treatment Outcome | Hepatitis C, Chronic - drug therapy | CD8-Positive T-Lymphocytes - physiology | CD8-Positive T-Lymphocytes - drug effects | Benzimidazoles - pharmacology | Aged | Cell Proliferation - drug effects | Thiazoles - pharmacology | In Vitro Techniques | Oligopeptides - pharmacology | Virus Replication - physiology | Ribavirin - pharmacology | Interferon | Biological response modifiers | T cells | Hepatitis C | Health aspects
Journal Article
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 07/2014, Volume 29, Issue 7, pp. 1477 - 1484
Journal Article
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 08/2016, Volume 31, Issue 8, pp. 1470 - 1475
Journal Article
FRONTIERS IN IMMUNOLOGY, ISSN 1664-3224, 09/2019, Volume 10
Chronic hepatitis B virus (HBV) infection is a major global health burden affecting around 257 million people worldwide. The consequences of chronic HBV... 
IMMUNE-RESPONSE | THERAPEUTIC VACCINE | CHRONIC HEPATITIS-B | exhaustion | SUSTAIN | IMMUNOLOGY | viral antigen | chronic HBV infection | RESTORES | PHASE | CD8(+) T cells | T-cell heterogeneity | DYSFUNCTION | RECEPTORS | PROTEINS | BLOCKADE | Infection | Antiviral agents | Liver | Immunotherapy | Control systems | T cells | Health aspects | Liver cirrhosis | Infection control | Hepatitis B | Usage | Diagnosis | Research | Risk factors | CD8+ T cells
Journal Article